#METABOLOMICS WORKBENCH  DATATRACK_ID:3913 STUDY_ID:ST002598 ANALYSIS_ID:AN004270
VERSION                          	1
CREATED_ON                       	02-08-2024
#PROJECT
PR:PROJECT_TITLE                 	MoTrPAC
PR:PROJECT_SUMMARY               	MoTrPAC is a national research consortium designed to discover and perform
PR:PROJECT_SUMMARY               	preliminary characterization of the range of molecular transducers (the
PR:PROJECT_SUMMARY               	"molecular map") that underlie the effects of physical activity in humans. The
PR:PROJECT_SUMMARY               	program's goal is to study the molecular changes that occur during and after
PR:PROJECT_SUMMARY               	exercise and ultimately to advance the understanding of how physical activity
PR:PROJECT_SUMMARY               	improves and preserves health. Preclinical and clinical studies will examine the
PR:PROJECT_SUMMARY               	systemic effects of endurance and resistance exercise across a range of ages and
PR:PROJECT_SUMMARY               	fitness levels by molecular probing of multiple tissues before and after acute
PR:PROJECT_SUMMARY               	and chronic exercise. This program is the largest targeted NIH investment of
PR:PROJECT_SUMMARY               	funds into the mechanisms of how physical activity improves health and prevents
PR:PROJECT_SUMMARY               	disease. The MoTrPAC program is supported by the NIH Common Fund and is managed
PR:PROJECT_SUMMARY               	by a trans-agency working group representing multiple NIH institutes and
PR:PROJECT_SUMMARY               	centers, led by the NIH Office of Strategic Coordination, National Institute of
PR:PROJECT_SUMMARY               	Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes
PR:PROJECT_SUMMARY               	and Digestive and Kidney Diseases, National Institute on Aging, and National
PR:PROJECT_SUMMARY               	Institute of Biomedical Imaging and Bioengineering. MoTrPAC Steering Committee:
PR:PROJECT_SUMMARY               	Wendy Kohrt, Chair, Russ Tracy, Co-Chair; NIH Program Manager, Concepcion
PR:PROJECT_SUMMARY               	Nierras. Euan Ashley and Matthew Wheeler are the PIs for the Motrpac
PR:PROJECT_SUMMARY               	Bioinformatics / Data Coordination Center.
PR:INSTITUTE                     	MoTrPAC
PR:LAST_NAME                     	Ashley
PR:FIRST_NAME                    	Euan
PR:ADDRESS                       	Falk Building CV267, 870 Quarry Road, Stanford, California 94305
PR:EMAIL                         	motrpac-data-deposition@lists.stanford.edu
PR:PHONE                         	(650) 725-1846
PR:DOI                           	http://dx.doi.org/10.21228/M8V97D
#STUDY
ST:STUDY_TITLE                   	MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Heart -
ST:STUDY_TITLE                   	Targeted Amines
ST:STUDY_SUMMARY                 	The goal of the endurance exercise training study in young adult rats (internal
ST:STUDY_SUMMARY                 	code: PASS1B-06) was to perform exercise training studies in adult (6 month)
ST:STUDY_SUMMARY                 	F344 rats, and from these rats collect as many tissues as feasible in order to
ST:STUDY_SUMMARY                 	provide high quality samples for detailed analysis by chemical analysis sites.
ST:STUDY_SUMMARY                 	Tissues were collected from 10-12 rats sedentary control rats concurrent with
ST:STUDY_SUMMARY                 	the collection of the 8-week training groups. The 8-week training group and
ST:STUDY_SUMMARY                 	controls were from the same cohort and same age at euthanasia (either 8). For
ST:STUDY_SUMMARY                 	the older age group, an additional set of controls (n=5-6) were collected with
ST:STUDY_SUMMARY                 	the 1-2 week training group. Rats were either sedentary or underwent an exercise
ST:STUDY_SUMMARY                 	training program. Rats were exercised on the rodent treadmill 5 days per week
ST:STUDY_SUMMARY                 	using a progressive training protocol designed to exercise the rats at
ST:STUDY_SUMMARY                 	approximately 70% of VO2max as outlined in the Table on the next page. Training
ST:STUDY_SUMMARY                 	was performed no earlier than 10:00 am and no later than 5:00 pm over 5
ST:STUDY_SUMMARY                 	consecutive days per week. Training was initiated with the treadmill set at 70%
ST:STUDY_SUMMARY                 	of VO2 max (see tables) and 5 degrees grade for 20 minutes. The duration of
ST:STUDY_SUMMARY                 	exercise was increased by one minute each day until day 31 of training (start of
ST:STUDY_SUMMARY                 	week 7), when a duration of 50 min was reached. Speed and grade of each training
ST:STUDY_SUMMARY                 	session increased in larger increments due to treadmill parameters. The highest
ST:STUDY_SUMMARY                 	intensity and duration of training began on day 31. This intensity was
ST:STUDY_SUMMARY                 	maintained for the final 10 days of the protocol to ensure steady state had been
ST:STUDY_SUMMARY                 	achieved. If any rats were unable to perform at least 4 days of training per
ST:STUDY_SUMMARY                 	week they were removed from the study and euthanized. It is important to note
ST:STUDY_SUMMARY                 	that the starting treadmill speed varied depending on the sex and age of the
ST:STUDY_SUMMARY                 	rat. The initial and maximum speeds were based on VO2max measurements obtained
ST:STUDY_SUMMARY                 	during the pre-training testing of the compliant rats. Rats assigned to the
ST:STUDY_SUMMARY                 	control group followed a schedule similar to the training group. They were
ST:STUDY_SUMMARY                 	placed in one lane on the treadmill for 15 minutes/day, 5 days per week. The
ST:STUDY_SUMMARY                 	treadmill was set at 0 m/min at an incline that corresponded to the incline
ST:STUDY_SUMMARY                 	being used by the training group.
ST:INSTITUTE                     	Mayo Clinic
ST:DEPARTMENT                    	Internal Medicine
ST:LABORATORY                    	Mayo Clinic Metabolomics Resource Core (MCMRC)
ST:LAST_NAME                     	Nair
ST:FIRST_NAME                    	K. Sreekumaran
ST:ADDRESS                       	200 1st St SW, Rochester, MN 55902
ST:EMAIL                         	nair@mayo.edu
ST:PHONE                         	(507) 284-2511
ST:SUBMIT_DATE                   	2023-04-28
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Rattus norvegicus
SU:TAXONOMY_ID                   	10116
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	1628FB23-6F66-47D4-8D82-63C87726F0FD	90245015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_35.RAW
SUBJECT_SAMPLE_FACTORS           	69FD4884-786D-4F2A-97B1-6174FBD25D60	90248015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_36.RAW
SUBJECT_SAMPLE_FACTORS           	07AF7369-F082-4CA7-99D5-D973F4A162C9	90252015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_39.RAW
SUBJECT_SAMPLE_FACTORS           	F9BEE1FA-E2DB-4BE4-A79C-99D585D6FD17	90265015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_43.RAW
SUBJECT_SAMPLE_FACTORS           	A77AC89A-1D9E-4516-9DA4-2BE99C8126EF	90266015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_44.RAW
SUBJECT_SAMPLE_FACTORS           	BC49E4EF-E2FE-4269-BAF0-461F768BD95D	90217015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_25.RAW
SUBJECT_SAMPLE_FACTORS           	0559B193-BED3-4170-B045-10A2B6441CB6	90229015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_31.RAW
SUBJECT_SAMPLE_FACTORS           	90CFE5A4-76FE-4458-A2B1-A66F0B60118E	90232015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_32.RAW
SUBJECT_SAMPLE_FACTORS           	F0D83B29-8EFA-4CDE-B1AA-2358AC220ECF	90237015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_33.RAW
SUBJECT_SAMPLE_FACTORS           	FCE9ABE6-B60B-4934-BAE5-56AF8B11ECEC	90239015812	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_34.RAW
SUBJECT_SAMPLE_FACTORS           	B73AB139-7210-4498-9CCF-E1DBE6EBA71C	90559015812	Group:Training | Timepoint:1 week of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_41.RAW
SUBJECT_SAMPLE_FACTORS           	EA5C8932-9325-4DA5-96BB-50CD49CEDD10	90560015812	Group:Training | Timepoint:1 week of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_42.RAW
SUBJECT_SAMPLE_FACTORS           	0645F621-878C-4C9B-84A6-58862BAA17D9	90564015812	Group:Training | Timepoint:1 week of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_43.RAW
SUBJECT_SAMPLE_FACTORS           	68083256-8DAA-4185-B446-0CAF600474B5	90567015812	Group:Training | Timepoint:1 week of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_44.RAW
SUBJECT_SAMPLE_FACTORS           	6A013AA1-4D1E-4B75-B691-6BA22D928E51	90571015812	Group:Training | Timepoint:1 week of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_45.RAW
SUBJECT_SAMPLE_FACTORS           	6D680EA2-C62B-4A35-8B6E-2ED6A79CB017	90421015812	Group:Training | Timepoint:1 week of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_30.RAW
SUBJECT_SAMPLE_FACTORS           	53F914B0-FD4F-4340-84A6-48341EAB3798	90422015812	Group:Training | Timepoint:1 week of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_31.RAW
SUBJECT_SAMPLE_FACTORS           	D350D633-8D95-4783-99F2-BB8294D2EC32	90423015812	Group:Training | Timepoint:1 week of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_32.RAW
SUBJECT_SAMPLE_FACTORS           	0DBFEB04-1B58-43CF-BAFD-9AA9915B67F6	90426015812	Group:Training | Timepoint:1 week of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_33.RAW
SUBJECT_SAMPLE_FACTORS           	10E282EB-1DBA-406E-BD5D-81027083A01D	90430015812	Group:Training | Timepoint:1 week of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_34.RAW
SUBJECT_SAMPLE_FACTORS           	B137E81D-A9DE-4E3A-8E2B-AD6C22920B7E	90576015812	Group:Training | Timepoint:2 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_46.RAW
SUBJECT_SAMPLE_FACTORS           	DC8B35E8-4AA8-4829-8569-F223D069620C	90578015812	Group:Training | Timepoint:2 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_47.RAW
SUBJECT_SAMPLE_FACTORS           	8904857C-2073-4BBA-AC7C-1EC239E5BFF7	90581015812	Group:Training | Timepoint:2 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_48.RAW
SUBJECT_SAMPLE_FACTORS           	1F9BD644-303F-43E7-94BE-FF6654306F5E	90585015812	Group:Training | Timepoint:2 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_49.RAW
SUBJECT_SAMPLE_FACTORS           	0409BED3-F9FE-4C06-9920-74F5E5CA04A3	90587015812	Group:Training | Timepoint:2 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_50.RAW
SUBJECT_SAMPLE_FACTORS           	4E974304-21EB-42E8-A729-A7FB6B406E64	90439015812	Group:Training | Timepoint:2 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_35.RAW
SUBJECT_SAMPLE_FACTORS           	6527EC12-E7EB-4F17-BF0A-0AC7CD1819A0	90441015812	Group:Training | Timepoint:2 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_36.RAW
SUBJECT_SAMPLE_FACTORS           	AEB1611A-F29E-43F8-B9F3-A2BC4F9EB504	90444015812	Group:Training | Timepoint:2 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_37.RAW
SUBJECT_SAMPLE_FACTORS           	FDA87A8D-3634-4C42-9A1A-0EA03B58BB01	90449015812	Group:Training | Timepoint:2 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_39.RAW
SUBJECT_SAMPLE_FACTORS           	CDCFA3F1-07ED-4737-A36D-15EFEC325AA5	90450015812	Group:Training | Timepoint:2 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=06jan21_40.RAW
SUBJECT_SAMPLE_FACTORS           	2E37478F-525F-4E5E-A882-EE75FD0CFB29	90406015812	Group:Training | Timepoint:4 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_25.RAW
SUBJECT_SAMPLE_FACTORS           	A9CE3E3D-31A0-4443-8A7F-8FD831D79248	90410015812	Group:Training | Timepoint:4 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_26.RAW
SUBJECT_SAMPLE_FACTORS           	3D5BC47C-BB3D-45A2-8DB8-D7ADCD51997C	90412015812	Group:Training | Timepoint:4 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_27.RAW
SUBJECT_SAMPLE_FACTORS           	89D6F615-D17C-4EB9-88EB-A602940FF179	90416015812	Group:Training | Timepoint:4 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_28.RAW
SUBJECT_SAMPLE_FACTORS           	FE012DC0-AF32-4C70-A4D4-F042B8BC4EC6	90420015812	Group:Training | Timepoint:4 weeks of training | Sex:Female	RAW_FILE_NAME=raw_file=06jan21_29.RAW
SUBJECT_SAMPLE_FACTORS           	22D700B9-EDD0-4BC8-8155-EB9C39417F81	90280015812	Group:Training | Timepoint:4 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_46.RAW
SUBJECT_SAMPLE_FACTORS           	1CA4210C-3CE6-4A5A-996B-673EBDEB3B81	90281015812	Group:Training | Timepoint:4 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_47.RAW
SUBJECT_SAMPLE_FACTORS           	9F3E1040-D409-421E-B635-2572DC20ED89	90283015812	Group:Training | Timepoint:4 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_48.RAW
SUBJECT_SAMPLE_FACTORS           	569A9229-04E8-414A-A195-FE9E8F1B66AB	90289015812	Group:Training | Timepoint:4 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_49.RAW
SUBJECT_SAMPLE_FACTORS           	E4271AF1-899A-4A65-9D8D-BF18CEE3F1CF	90292015812	Group:Training | Timepoint:4 weeks of training | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_50.RAW
SUBJECT_SAMPLE_FACTORS           	0D5071F5-D166-4CF1-BE8B-EB4DF6E04C0E	90251015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_37.RAW
SUBJECT_SAMPLE_FACTORS           	2479BEE5-2A38-4D09-B15B-B1715F561A9F	90254015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_40.RAW
SUBJECT_SAMPLE_FACTORS           	0A4A7935-3AF4-463F-84E3-DCF07671509D	90258015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_41.RAW
SUBJECT_SAMPLE_FACTORS           	04C84D7E-FC8C-422F-AE4B-CAFADB63407B	90259015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_42.RAW
SUBJECT_SAMPLE_FACTORS           	2B969165-1A52-43AA-8FD9-39AFA62F094F	90267015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	RAW_FILE_NAME=raw_file=04jan21_45.RAW
SUBJECT_SAMPLE_FACTORS           	0BD282C7-7832-4581-9089-08A32D557034	90218015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_26.RAW
SUBJECT_SAMPLE_FACTORS           	955498F4-70A0-4D50-A2BA-619A8FED8FEF	90222015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_27.RAW
SUBJECT_SAMPLE_FACTORS           	CFE06932-9314-4BCC-B2D9-73883D5FCDFB	90223015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_28.RAW
SUBJECT_SAMPLE_FACTORS           	3719CB62-B551-49BE-94A0-E51DFE13D30D	90225015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_29.RAW
SUBJECT_SAMPLE_FACTORS           	F65955CE-E49F-48C7-B861-02A2FDF6F9B8	90227015812	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	RAW_FILE_NAME=raw_file=04jan21_30.RAW
#COLLECTION
CO:COLLECTION_SUMMARY            	-
CO:SAMPLE_TYPE                   	Heart
#TREATMENT
TR:TREATMENT_SUMMARY             	-
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	homogenized in PBS, isotope IS added, deproteinized
SP:SAMPLEPREP_PROTOCOL_FILENAME  	pass1b_experimental_design_metabolomics.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Analytes were chromatographically separated with 40 minutes LC gradient
CH:METHODS_FILENAME              	pass1b_amines_methods.pdf
CH:INSTRUMENT_NAME               	Waters Acquity UPLC
CH:COLUMN_NAME                   	Waters Acquity UPLC BEH C8 (150 x 2.1mm, 1.7um)
CH:COLUMN_TEMPERATURE            	43C
CH:FLOW_GRADIENT                 	t=0 min: 99.9%/0.1% (%A/%B) @ 0.4 ml/min | t=1 min: 99.9%/0.1% (%A/%B) @ 0.4
CH:FLOW_GRADIENT                 	ml/min | t=2 min: 99.9%/0.1% (%A/%B) @ 0.4 ml/min | t=5.5 min: 98.1%/1.9%
CH:FLOW_GRADIENT                 	(%A/%B) @ 0.4 ml/min | t=6.5 min: 98%/2% (%A/%B) @ 0.4 ml/min | t=10 min:
CH:FLOW_GRADIENT                 	97.5%/2.4% (%A/%B) @ 0.4 ml/min | t=12 min: 96%/4% (%A/%B) @ 0.4 ml/min | t=20
CH:FLOW_GRADIENT                 	min: 88%/12% (%A/%B) @ 0.4 ml/min | t=27 min: 86.5%/13.5% (%A/%B) @ 0.4 ml/min |
CH:FLOW_GRADIENT                 	t=31 min: 80%/20% (%A/%B) @ 0.4 ml/min | t=32 min: 2%/98% (%A/%B) @ 0.5 ml/min |
CH:FLOW_GRADIENT                 	t=35 min: 2%/98% (%A/%B) @ 0.5 ml/min | t=35.5 min: 99.9%/0.1% (%A/%B) @ 0.4
CH:FLOW_GRADIENT                 	ml/min | t=39 min: 99.9%/0.1% (%A/%B) @ 0.4 ml/min
CH:FLOW_RATE                     	0.4 ml/min; 0.5 ml/min
CH:SOLVENT_A                     	1% acetonitrile/99% water; 0.1% formic acid
CH:SOLVENT_B                     	1% water/99% acetonitrile
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo TSQ Quantiva
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	Multiple reaction monitoring mode (MRM); peak integration, concentrations
MS:MS_COMMENTS                   	calculated against multi-point standard curves;
MS:ION_MODE                      	POSITIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	nano moles per vial
MS_METABOLITE_DATA_START
Samples	90245015812	90248015812	90252015812	90265015812	90266015812	90217015812	90229015812	90232015812	90237015812	90239015812	90559015812	90560015812	90564015812	90567015812	90571015812	90421015812	90422015812	90423015812	90426015812	90430015812	90576015812	90578015812	90581015812	90585015812	90587015812	90439015812	90441015812	90444015812	90449015812	90450015812	90406015812	90410015812	90412015812	90416015812	90420015812	90280015812	90281015812	90283015812	90289015812	90292015812	90251015812	90254015812	90258015812	90259015812	90267015812	90218015812	90222015812	90223015812	90225015812	90227015812
Factors	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	Group:Control | Timepoint:8 weeks of training or control time | Sex:Female	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	Group:Control | Timepoint:8 weeks of training or control time | Sex:Male	Group:Training | Timepoint:1 week of training or control time | Sex:Female	Group:Training | Timepoint:1 week of training or control time | Sex:Female	Group:Training | Timepoint:1 week of training or control time | Sex:Female	Group:Training | Timepoint:1 week of training or control time | Sex:Female	Group:Training | Timepoint:1 week of training or control time | Sex:Female	Group:Training | Timepoint:1 week of training or control time | Sex:Male	Group:Training | Timepoint:1 week of training or control time | Sex:Male	Group:Training | Timepoint:1 week of training or control time | Sex:Male	Group:Training | Timepoint:1 week of training or control time | Sex:Male	Group:Training | Timepoint:1 week of training or control time | Sex:Male	Group:Training | Timepoint:2 weeks of training | Sex:Female	Group:Training | Timepoint:2 weeks of training | Sex:Female	Group:Training | Timepoint:2 weeks of training | Sex:Female	Group:Training | Timepoint:2 weeks of training | Sex:Female	Group:Training | Timepoint:2 weeks of training | Sex:Female	Group:Training | Timepoint:2 weeks of training | Sex:Male	Group:Training | Timepoint:2 weeks of training | Sex:Male	Group:Training | Timepoint:2 weeks of training | Sex:Male	Group:Training | Timepoint:2 weeks of training | Sex:Male	Group:Training | Timepoint:2 weeks of training | Sex:Male	Group:Training | Timepoint:4 weeks of training | Sex:Female	Group:Training | Timepoint:4 weeks of training | Sex:Female	Group:Training | Timepoint:4 weeks of training | Sex:Female	Group:Training | Timepoint:4 weeks of training | Sex:Female	Group:Training | Timepoint:4 weeks of training | Sex:Female	Group:Training | Timepoint:4 weeks of training | Sex:Male	Group:Training | Timepoint:4 weeks of training | Sex:Male	Group:Training | Timepoint:4 weeks of training | Sex:Male	Group:Training | Timepoint:4 weeks of training | Sex:Male	Group:Training | Timepoint:4 weeks of training | Sex:Male	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	Group:Training | Timepoint:8 weeks of training or control time | Sex:Female	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	Group:Training | Timepoint:8 weeks of training or control time | Sex:Male	
1-Methylhistidine	0.0314	0.0458	0.0249		0.0240	0.0790	0.0782	0.0504	0.0701	0.0425			0.0444	0.0234		0.0277	0.0332	0.0793	0.0316	0.0510		0.0416	0.0314	0.0396		0.0473	0.0465	0.0810	0.0397	0.0412	0.0251		0.0215			0.0627	0.0262	0.0876	0.0515	0.0605	0.0209		0.0191			0.0578	0.0547	0.0464	0.0252	0.0688
3-Methylhistidine	0.0239										0.0282			0.0428	0.0193	0.0329						0.0791	0.0394	0.0181						0.0154			0.0405	0.0453		0.0102	0.0203		0.0238				0.0267		0.0178		0.0176			0.0187
Alanine	8.2605	6.1720	7.6745	7.8149	7.0899	13.5884	11.2455	8.5998	6.8609	7.4255	8.0081	6.1433	7.2033	6.1464	5.9130	6.7804	8.5033	7.6914	7.1773	5.7961	9.1787	6.3424	6.2146	7.3384	6.2576	5.3962	6.5650	6.3835	6.2269	6.1359	6.0623	7.0385	6.5216	5.9604	6.0392	8.6454	7.3055	7.1808	8.0989	7.2984	12.8886	7.8172	7.6573	6.8039	8.4300	9.2379	11.5279	8.1436	8.0441	9.1077
alpha-Aminoadipic-acid	0.0069	0.0037	0.0037	0.0063	0.0057	0.0055	0.0080	0.0041	0.0063	0.0031	0.0085	0.0076	0.0114	0.0107	0.0100	0.0083	0.0090	0.0089	0.0095	0.0075	0.0128	0.0120	0.0111	0.0139	0.0125	0.0071	0.0094	0.0086	0.0068	0.0073	0.0090	0.0091	0.0065	0.0067	0.0059	0.0092	0.0071	0.0043	0.0083	0.0075	0.0121	0.0045	0.0031	0.0026	0.0061	0.0018	0.0091	0.0059	0.0047	0.0040
alpha-Amino-N-butyric-acid	0.1054	0.0768	0.1104	0.0185	0.0888	0.0307	0.0403	0.0308	0.0226	0.0222	0.1185	0.0666	0.1631	0.1378	0.0952	0.0302	0.0306	0.0264	0.0341	0.0300	0.1533	0.1110	0.1335	0.1119	0.1416	0.0368	0.0197	0.0639	0.0215	0.0324	0.0525	0.0809	0.0252	0.0411	0.0458	0.0346	0.0201	0.0404	0.0390	0.0319	0.1425	0.0930	0.0359	0.0272	0.0377	0.0341	0.0306	0.0296	0.0247	0.0209
Anserine	0.1852	0.1695	0.1556	0.1744	0.1943	0.2958	0.4698	0.2744	0.2728	0.2819	0.1624	0.2047	0.2548	0.2242	0.2010	0.2534	0.2832	0.2931	0.2241	0.2509	0.1728	0.2361	0.1840	0.2402	0.2295	0.1866	0.2274	0.2337	0.2051	0.2553	0.2286	0.1989	0.1875	0.1615	0.1884	0.3025	0.2606	0.2356	0.2648	0.2647	0.2532	0.1373	0.1636	0.1876	0.1680	0.3278	0.3041	0.2561	0.2831	0.2581
Arginine	1.0379	1.0320	0.8875	0.9665	1.2028	1.1188	1.7347	1.0262	1.2795	1.0504	0.8762	0.8184	1.3326	1.1091	1.1426	0.8349	1.1404	0.8448	1.1610	0.9442	1.1334	1.1638	1.1125	1.3918	1.3762	0.7426	1.0843	1.1846	0.9869	1.1865	1.0811	1.3794	1.4612	1.2893	1.1484	1.2835	1.5598	1.1735	1.2737	1.6639	1.9967	1.2435	1.5102	1.5662	1.4700	1.4595	2.2818	1.7703	1.5856	1.6129
Asparagine	1.6100	1.6193	1.5111	1.6652	2.1076	1.5304	1.9842	1.6770	1.8028	1.4873	1.2826	1.4762	1.8394	1.8067	1.4058	1.4275	1.4721	1.3991	1.5532	1.4891	1.4473	2.0502	1.5405	1.7894	2.1470	1.0456	1.5680	1.7178	1.2641	1.4260	1.7583	2.2565	1.7294	1.5971	1.6995	1.7787	1.8298	1.6174	2.0485	2.3426	3.6294	1.7596	1.9847	1.9633	2.3612	1.9108	2.8508	2.1853	2.0321	2.2060
Aspartic Acid	7.7955	7.8591	9.6657	8.2979	11.5073	10.1239	9.3216	8.8688	7.8992	7.9014	6.9720	8.1465	11.3446	9.1805	8.7356	7.3440	6.2636	6.8106	8.4941	8.8229	7.4601	8.6953	10.6936	9.4828	9.4883	8.5626	8.3029	12.8075	7.4201	8.8448	6.5378	8.2566	6.9183	6.9784	8.2418	10.9805	8.8698	11.6202	11.1728	10.9937	15.7576	9.5022	7.8628	9.0057	10.4137	9.8927	10.6171	12.7951	6.2633	8.6162
beta-Alanine	0.0250	0.0190	0.0150	0.0167	0.0258	0.0619	0.1073	0.0706	0.0675	0.0470	0.0554	0.0650	0.0817	0.0782	0.0650	0.0891	0.1015	0.0999	0.0958	0.0819	0.0626	0.0870	0.0804	0.0806	0.0883	0.0449	0.0874	0.0977	0.0645	0.0861	0.0494	0.0580	0.0498	0.0382	0.0477	0.0728	0.0676	0.0464	0.0846	0.1025	0.1036	0.0046		0.0294	0.0317	0.0299	0.1642	0.0624	0.0498	0.0588
beta-Aminoisobutyric-acid																																																		
Carnosine	0.6156	0.5643	0.4611	0.5062	0.5348	0.8986	1.2538	0.7990	0.8726	0.7957	0.4681	0.5494	0.6472	0.5316	0.4525	0.6063	0.6513	0.7167	0.5622	0.5532	0.5172	0.5468	0.4031	0.5137	0.4779	0.4098	0.4715	0.5639	0.5118	0.7230	0.4987	0.4721	0.4504	0.3879	0.4378	0.7348	0.7106	0.6068	0.7270	0.7558	0.8310	0.4250	0.4612	0.5268	0.4788	0.7582	0.7432	0.7411	0.7401	0.6963
Citrulline	0.8504	0.7664	0.8109	0.9271	0.9326	0.5648	0.6916	0.4980	0.5556	0.4610	0.9996	0.8706	1.1874	1.2861	0.9897	0.6182	0.6504	0.7273	0.6573	0.7455	0.8385	1.4204	1.2146	1.3449	1.5339	0.4137	0.5702	0.8460	0.5756	0.6392	1.1736	1.2870	0.9970	1.0704	1.0360	0.5108	0.5981	0.4941	0.6853	0.5559	1.5185	0.7063	0.7271	0.9214	1.0577	0.5428	0.7677	0.5352	0.5115	0.5267
Cystathionine 1	0.0087	0.0088	0.0091	0.0102	0.0081	0.0085	0.0122	0.0084	0.0094	0.0084	0.0072	0.0078	0.0085	0.0089	0.0106	0.0088	0.0063	0.0072	0.0059	0.0056	0.0063	0.0100	0.0066	0.0074	0.0132	0.0045	0.0082	0.0079	0.0053	0.0098	0.0116	0.0071	0.0059	0.0048	0.0079	0.0058	0.0057	0.0103	0.0065	0.0085	0.0087	0.0068	0.0072	0.0086	0.0070	0.0060	0.0090	0.0060	0.0061	0.0076
Cysteine	0.0040	0.0068	0.0058	0.0092	0.0101	0.0096	0.0131	0.0107	0.0077	0.0096	0.0057	0.0040	0.0124	0.0058	0.0040	0.0048	0.0062	0.0036	0.0034	0.0066	0.0041	0.0060	0.0060	0.0096	0.0104	0.0019	0.0052	0.0034	0.0038	0.0045	0.0071	0.0054	0.0046	0.0045	0.0036	0.0087	0.0080	0.0058	0.0109	0.0065	0.0126	0.0048	0.0032	0.0072	0.0120	0.0117	0.0161	0.0123	0.0113	0.0081
Ethanolamine	0.1965	0.1877	0.2190	0.1762	0.2641	0.2612	0.2574	0.2315	0.2471	0.1957	0.1948	0.2328	0.3390	0.2779	0.2489	0.2374	0.2388	0.2284	0.2951	0.2382	0.2019	0.2957	0.2925	0.2984	0.2940	0.1954	0.2414	0.3302	0.2151	0.2210	0.2269	0.2677	0.1872	0.2037	0.2333	0.2818	0.2469	0.2514	0.3236	0.2857	0.3831	0.2022	0.1963	0.2156	0.2909	0.2364	0.3488	0.3127	0.2490	0.2134
gamma-Amino-N-butyric-acid	0.0216	0.0179	0.0210	0.0200	0.0230	0.0253	0.0289	0.0214	0.0207	0.0245	0.0214	0.0267	0.0253	0.0276	0.0221	0.0220	0.0234	0.0306	0.0223	0.0247	0.0255	0.0280	0.0241	0.0367	0.0237	0.0166	0.0302	0.0229	0.0182	0.0225	0.0199	0.0266	0.0214	0.0210	0.0210	0.0148	0.0200	0.0171	0.0357	0.0221	0.0433	0.0163	0.0171	0.0199	0.0218	0.0169	0.0372	0.0253	0.0253	0.0192
Glutamic Acid	14.6994	15.1406	9.0785	11.5100	11.1603	9.3444	16.4505	16.9325	18.7359	15.2021	11.9201	12.3053	14.8448	16.5351	11.4662	16.4816	18.7421	18.1410	16.8072	15.8552	12.6800	20.0744	12.9529	16.3096	20.3191	8.7891	18.3599	17.3862	12.7154	14.5758	18.3560	17.9727	15.7557	13.9719	14.5183	15.3768	15.7648	9.7149	18.5639	20.1208	22.2483	11.0623	13.2386	16.0181	14.9578	14.4865	24.0356	14.9909	20.9457	18.3307
Glutamine	37.7874	35.3130	35.4446	31.9415	39.9128	44.0555	53.4131	46.3724	39.7839	37.9102	32.9777	32.9346	45.1377	42.3423	36.0251	41.3124	44.4561	44.0284	42.4048	41.7183	35.0651	44.1739	38.7134	40.7722	48.2617	30.0096	42.9079	57.4135	36.2616	43.5913	45.8806	48.5332	35.8993	33.7315	40.5155	38.8173	39.8220	37.6677	43.3395	46.6041	70.0135	32.7812	34.3795	37.2754	43.2673	47.3538	61.3288	53.0777	45.5689	44.6608
Glycine	1.9944	1.8154	1.9708	1.9991	2.3167	2.3256	2.4707	2.2215	2.1903	2.0355	2.0276	1.9685	2.8058	2.3831	2.0236	2.0051	2.2889	2.0845	2.1085	1.9664	2.0464	2.5959	2.3909	2.4138	2.7765	1.6907	2.4866	2.3229	1.7605	2.1601	2.0060	2.2897	1.9334	1.8674	2.0131	2.3042	2.3143	2.1585	2.4586	2.8018	3.2612	2.1026	2.1008	2.3336	2.5644	2.3753	3.2646	2.5529	2.2066	2.0659
Histidine	0.9671	0.8668	0.7368	0.8430	0.9034	1.3692	1.7160	1.3530	1.2706	1.3252	0.9081	0.7899	1.0268	0.7619	0.8465	1.1159	1.1482	1.0474	1.2301	1.0514	0.7321	0.7539	0.7160	0.8428	0.8693	0.7532	0.9254	1.3518	1.1823	1.2060	1.3277	1.2224	1.3304	1.1442	1.1722	0.9250	1.0995	0.7258	0.9869	1.1030	1.6187	0.7564	1.0106	1.1030	1.0623	1.5221	1.7595	1.6656	1.3346	1.7969
Homocysteine																																																		
Hydroxylysine													0.0005		0.0003			0.0003													0.0006										0.0003						0.0002			
Hydroxyproline	0.1256	0.1099	0.0945	0.1014	0.1236	0.1891	0.2553	0.1826	0.1790	0.1466	0.1014	0.0928	0.1313	0.1249	0.1125	0.1557	0.1716	0.1514	0.1590	0.1387	0.0934	0.1181	0.1070	0.1375	0.1372	0.1066	0.1613	0.1583	0.1275	0.1644	0.1150	0.1193	0.1191	0.0878	0.0990	0.2290	0.2531	0.1692	0.1924	0.2058	0.1886	0.1217	0.1066	0.1207	0.1217	0.1762	0.2151	0.1939	0.1644	0.1810
Isoleucine	0.4321	0.3815	0.4693	0.3852	0.5003	0.5146	0.5304	0.4629	0.4442	0.3899	0.3942	0.3073	0.5964	0.4473	0.3645	0.3344	0.4117	0.3656	0.4260	0.3468	0.4586	0.5094	0.4118	0.4868	0.5464	0.2757	0.3935	0.4169	0.3180	0.3430	0.4060	0.4645	0.3518	0.3465	0.3749	0.4297	0.4011	0.3307	0.5151	0.4856	0.8908	0.4015	0.4800	0.4110	0.4998	0.4159	0.8603	0.4278	0.4647	0.5176
Leucine	1.0397	0.8959	1.0323	0.9164	1.1412	1.1570	1.1957	1.1142	1.0608	0.9448	0.9421	0.7538	1.2840	1.0628	0.8283	0.7867	0.9486	0.9273	0.9624	0.8028	1.0374	1.1540	0.9550	1.0991	1.1838	0.6615	0.9426	0.9199	0.7278	0.7942	0.9120	1.1253	0.8605	0.8013	0.8854	1.0443	0.9846	0.7695	1.1347	1.1543	1.9436	0.8923	1.1041	0.9447	1.1378	0.9730	1.9690	1.0144	1.1741	1.2654
Lysine	2.5001	2.1471	2.1762	2.0619	2.5901	2.2066	2.7676	2.0741	2.3120	1.8294	2.6463	2.2518	3.6661	3.5208	3.1311	2.1944	2.6084	2.5633	2.6198	2.3400	3.6211	3.6855	3.2502	3.9936	4.5186	1.8952	2.6821	2.8654	2.0032	2.5876	3.3999	3.4533	2.6618	2.6039	2.8201	2.8125	3.0828	2.5670	2.5210	2.9968	4.5268	2.5424	2.8669	2.9799	3.1656	2.8529	4.2666	3.5088	3.0345	3.0321
Methionine	0.2906	0.2494	0.2786	0.2864	0.3151	0.3335	0.3625	0.3178	0.3320	0.2938	0.2507	0.2262	0.3452	0.3046	0.2580	0.2544	0.3159	0.3213	0.3169	0.2823	0.2716	0.3326	0.2984	0.3352	0.3730	0.2347	0.3406	0.3428	0.2449	0.3046	0.3047	0.3208	0.2966	0.2476	0.2593	0.3347	0.3263	0.2670	0.3510	0.4044	0.5274	0.2746	0.3195	0.3411	0.3898	0.3376	0.4315	0.3810	0.3826	0.3761
Ornithine	0.0492	0.0478	0.0559	0.0652	0.0654	0.1034	0.0715	0.0680	0.0642	0.0546	0.0539	0.0542	0.0869	0.0692	0.0592	0.0614	0.0642	0.0650	0.0661	0.0618	0.0554	0.0633	0.0623	0.0719	0.0695	0.0420	0.0776	0.0692	0.0430	0.0519	0.0614	0.0625	0.0591	0.0544	0.0555	0.0733	0.0662	0.0541	0.1290	0.0755	0.0822	0.0582	0.0603	0.0619	0.0673	0.0633	0.1007	0.0697	0.0762	0.0749
Phenylalanine	0.4195	0.3686	0.4706	0.4140	0.4756	0.5193	0.5279	0.4801	0.4516	0.4444	0.4016	0.3248	0.5329	0.4526	0.3644	0.3614	0.4307	0.4198	0.4300	0.4114	0.4144	0.4428	0.4188	0.4836	0.4475	0.3028	0.4916	0.4415	0.3380	0.3960	0.3651	0.4408	0.4031	0.3679	0.3658	0.4825	0.4369	0.3856	0.5068	0.5365	0.7474	0.3626	0.4585	0.4433	0.5064	0.4645	0.9495	0.4971	0.5027	0.5521
Phosphoethanolamine	1.4612	1.4124	1.2718	1.0353	1.7478	1.4208	1.6475	1.3420	1.4346	1.6146	1.1244	1.1249	1.7549	1.7033	1.6111	1.2958	1.2123	1.3158	1.4634	1.1647	1.5196	1.8004	1.5808	1.7486	1.7592	0.9526	1.5985	1.6714	1.1904	1.1819	1.1693	1.6185	1.2094	1.0763	1.3069	1.4122	1.6937	1.3876	2.0780	2.1075	3.0558	1.7796	1.8143	1.4686	1.3935	0.9562	1.4724	1.6633	1.5646	1.3295
Proline	0.4058	0.3480	0.3575	0.4292	0.4114	0.4964	0.4488	0.4189	0.4327	0.4107	0.3606	0.3411	0.4872	0.4211	0.3791	0.3511	0.4216	0.4489	0.4186	0.3923	0.3844	0.4552	0.4030	0.4675	0.4728	0.3057	0.4257	0.4324	0.3557	0.3776	0.3882	0.4525	0.4447	0.4066	0.3915	0.4422	0.4524	0.3310	0.4694	0.4762	0.6575	0.3922	0.4306	0.4645	0.4884	0.4654	0.9318	0.5667	0.4988	0.5511
Sarcosine	0.0044	0.0041	0.0045	0.0052	0.0062	0.0049	0.0044	0.0042	0.0037	0.0044	0.0049	0.0037	0.0098	0.0054	0.0044	0.0029	0.0035	0.0038	0.0035	0.0032	0.0041	0.0058	0.0055	0.0057	0.0081	0.0031	0.0037	0.0040	0.0035	0.0036	0.0053	0.0057	0.0036	0.0030	0.0048	0.0038	0.0045	0.0039	0.0033	0.0053	0.0077	0.0041	0.0046	0.0047	0.0059	0.0040	0.0086	0.0042	0.0051	0.0060
Serine	1.2771	1.1310	1.1120	1.1711	1.3550	1.4192	1.3378	1.1030	1.1912	1.0252	1.2418	1.2713	1.7199	1.7626	1.5297	1.1060	1.4207	1.3152	1.3603	1.2375	1.3444	1.7962	1.4943	1.7799	1.8151	1.0790	1.6432	1.6435	1.1983	1.3071	1.5669	1.7340	1.6176	1.4252	1.5423	1.3703	1.4059	1.1580	1.5816	1.8266	2.6451	1.4515	1.4774	1.5855	1.7364	1.4186	2.4355	1.6782	1.5510	1.3943
Taurine	55.7215	54.9382	50.7622	56.1311	59.3215	72.9717	75.2110	70.7860	64.4886	63.0192	56.6737	63.6036	65.0495	64.4668	53.6176	67.6513	72.3786	69.7912	70.0770	63.3207	56.1364	63.7232	64.0564	68.1766	67.6648	51.9113	69.3521	66.0228	58.4538	66.0626	58.5370	63.7517	58.7134	59.4059	58.5833	71.4259	66.1263	58.5211	72.5730	77.0121	82.8585	51.4297	62.9661	64.8151	65.7276	75.8540	87.3782	76.0586	68.5354	70.0386
Threonine	1.3174	1.0226	1.1703	1.0810	1.2959	1.3270	1.4454	1.2439	1.3122	1.0430	0.8995	0.8724	1.4308	1.4503	1.2204	1.0087	1.2826	1.2468	1.2241	1.1389	1.1506	1.5782	1.3169	1.4902	1.5875	0.9458	1.2932	1.6540	0.9660	1.1634	1.2591	1.4858	1.1760	1.1891	1.1621	1.2656	1.3114	1.1497	1.4223	1.5125	2.2083	1.1186	1.3890	1.2759	1.5558	1.4575	2.2394	1.6822	1.5746	1.4507
Tryptophan	0.1639	0.1602	0.1825	0.1747	0.1921	0.2071	0.2124	0.1984	0.1971	0.1629	0.1669	0.1472	0.2540	0.2088	0.1589	0.1565	0.1736	0.1575	0.1672	0.1709	0.1759	0.2071	0.1905	0.2281	0.2328	0.1061	0.1856	0.1750	0.1381	0.1601	0.1596	0.1865	0.1594	0.1547	0.1530	0.1995	0.1953	0.1479	0.1968	0.1975	0.2858	0.1477	0.1668	0.1802	0.2097	0.1791	0.3107	0.1824	0.2070	0.2125
Tyrosine	0.3517	0.3212	0.4189	0.3563	0.4665	0.4453	0.5036	0.4395	0.4391	0.3942	0.3509	0.2737	0.4951	0.4253	0.3352	0.3262	0.4217	0.3519	0.3886	0.3568	0.3061	0.4051	0.3718	0.4273	0.4346	0.2716	0.4185	0.4811	0.3296	0.3892	0.3585	0.4456	0.4124	0.3748	0.3570	0.4055	0.4291	0.3559	0.4386	0.4347	0.6951	0.3441	0.4094	0.4074	0.4801	0.4247	0.9725	0.4894	0.4807	0.5357
Valine	0.9259	0.7998	0.8808	0.7142	0.9350	1.0113	1.0080	1.0421	0.9433	0.8910	0.7501	0.5397	1.0003	0.8357	0.6771	0.6586	0.7478	0.7455	0.8016	0.6549	0.7323	0.7930	0.7495	0.8176	0.8872	0.5413	0.7713	0.9313	0.6706	0.6966	0.7838	0.8635	0.6827	0.6732	0.7368	0.8255	0.7072	0.6284	0.9072	0.8700	1.6684	0.8021	0.9211	0.7850	0.9764	0.9758	1.7313	0.9750	1.0604	1.1263
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	pubchem_id	inchi_key	kegg_id	other_id	other_id_type	ri	ri_type	moverz_quant	
1-Methylhistidine						4.1		340.6	
3-Methylhistidine						4.3		340.6	
Alanine						13.3		260.3	
alpha-Aminoadipic-acid						15.07		332.3	
alpha-Amino-N-butyric-acid						17.26		274.3	
Anserine						5.61		206.3	
Arginine						5.1		345.3	
Asparagine						4.4		303.3	
Aspartic Acid						7.7		304.3	
beta-Alanine						10.1		260.3	
beta-Aminoisobutyric-acid						15.35		274.3	
Carnosine						5.1		199.3	
Citrulline						9.3		346.3	
Cystathionine 1						17.55		282.3	
Cysteine						18.76		291.3	
Ethanolamine						6.36		232.3	
gamma-Amino-N-butyric-acid						13.7		274.3	
Glutamic Acid						9.5		318.35	
Glutamine						5.78		317.35	
Glycine						6.4		246.25	
Histidine						3.7		163.9	
Homocysteine						25.59		303.3	
Hydroxylysine						15.9		252.3	
Hydroxyproline						3.9		302.2	
Isoleucine						25.07		302.2	
Leucine						25.77		302.2	
Lysine						18.73		244.3	
Methionine						19.97		320.2	
Ornithine						17.45		237.3	
Phenylalanine						27.15		336.3	
Phosphoethanolamine						4.58		312.2	
Proline						15.4		286.3	
Sarcosine						8.4		260.3	
Serine						5.69		276.25	
Taurine						5.28		296.2	
Threonine						11.4		290.3	
Tryptophan						28.91		375.3	
Tyrosine						19.68		352.3	
Valine						20.47		288.3	
METABOLITES_END
#END